NB‐UVB vs medium‐dose UVA‐1 phototherapy (50 J/cm²)
Secondary outcome: Improvement of disease activity (skin softening) · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…
1 finding from 1 review
- no estimate extracted1 study · 28 participantsLow